BRI was certified as a joint usage/research center by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in 2010. Our extensive collection of brain disease materials and expertise have been open to the neuroscientists' community in Japan. BRI's diverse joint researches in neuropathology and related fields have brought out a great deal of achievement in relation to unravelling the pathological mechanism of brain disease.
Given the MEXT's recognition for such achievements, BRI has renewed the certification of a joint usage/research center in FY 2016.
Name: The collaborative research center for brain diseases utilizing neuropathological resources
Period: April 1, 2016 - March 31, 2022
BRI has the world-class collections of neuropathological specimens and advanced imaging analysis technique. BRI is committed to tackle tasks such as neuropathological analysis on brain disorders like Alzheimer's disease, development of early diagnostic technique, and translational research on the treatment for reducing disease progression.
By utilizing the specimens of human brain disease and the animal model resources along with the underpinning of translational research for clinical application, BRI's collaboration with researchers across the world offers a prospect of reducing the burden of intractable neurological disease. Expected outcomes include the followings: to shed light on the disease pathology, to establish early imaging diagnostics and to discover new treatment that slows disease progression.